Traveka Wealth LLC Purchases 50 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Traveka Wealth LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,025 shares of the healthcare conglomerate’s stock after acquiring an additional 50 shares during the period. Traveka Wealth LLC’s holdings in UnitedHealth Group were worth $599,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in UNH. XML Financial LLC lifted its position in UnitedHealth Group by 6.7% during the fourth quarter. XML Financial LLC now owns 3,518 shares of the healthcare conglomerate’s stock valued at $1,852,000 after buying an additional 221 shares during the period. Regal Investment Advisors LLC raised its position in shares of UnitedHealth Group by 5.1% in the 4th quarter. Regal Investment Advisors LLC now owns 3,379 shares of the healthcare conglomerate’s stock worth $1,779,000 after purchasing an additional 164 shares during the last quarter. Keyes Stange & Wooten Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $244,000. Whitford Management LLC raised its position in shares of UnitedHealth Group by 3,609.6% in the 4th quarter. Whitford Management LLC now owns 34,425 shares of the healthcare conglomerate’s stock worth $18,124,000 after purchasing an additional 33,497 shares during the last quarter. Finally, Visionary Wealth Advisors raised its position in shares of UnitedHealth Group by 3.2% in the 4th quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock worth $649,000 after purchasing an additional 38 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $0.01 during trading on Tuesday, hitting $583.57. 489,300 shares of the stock were exchanged, compared to its average volume of 3,940,527. The stock has a market cap of $537.11 billion, a PE ratio of 35.55, a P/E/G ratio of 1.65 and a beta of 0.58. The stock’s fifty day moving average is $582.58 and its 200 day moving average is $528.49. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period in the prior year, the firm earned $6.14 earnings per share. The business’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on UNH shares. Argus lifted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial raised their target price on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.